staar.com (STAA): Rentabilitas operasi

STAAR Surgical Company (STAA) - logo korporat

The stability of STAAR Surgical Company (STAA) is confirmed by its resilience to Asian geopolitical risks, which, while tracking the core operating profit margin on GURU.Markets, we note via 6.70, serving as the current metric level. The operational base relies on a balance of the defensive healthcare sector with elective services and a strong R&D pipeline that eliminates any competency gaps. Such a foundation guarantees cost control and provides a margin of safety for the business.

STAA - Rasio bathi operasi STAAR Surgical ing rentang 04.07.2022 - 20.11.2026

STAA (STAAR Surgical): rincian analitis lan laporan miturut indikator

- rega saham lan konsensus proyeksi valuasi:
Pambiji fundamental:STAAR Surgical Co., STAA
Barang utama staar.com

For STAAR Surgical Company (STAA), the operating profit margin on GURU.Markets reflects the production efficiency of implantable lenses. This metric is calculated as the ratio of operating profit to revenue, excluding the impact of taxes and debt obligations. The metric measures the business's ability to convert sales into profit before financial leverage. High margins confirm the scalability of the unique automation technology for miniature products. Steady growth in this indicator testifies to the fundamental stability and high profitability of the model.

Pesaing utama

ISRG (intuitive.com) - Margin operasi|Rentabilitas dodolan miturut bathi operasi DHR (Danaher Corp.)|Margin dodolan operasi BDX (Becton, Dickinson and Company)|Rasio bathi operasi STE|Rentabilitas operasi West Pharma WST|Rentabilitas kegiatan operasi Baxter (BAX)|MASI - Rentabilitas operasi|Rentabilitas kegiatan operasi Stevanato Group Corp STVN|TFX: Margin operasi|Margin dodolan operasi Merit Medical Systems|Rentabilitas operasi Envista Holdings Corp|Margin dodolan operasi ICU Medical Corp (ICUI)|Rentabilitas operasi DENTSPLY SIRONA Inc. (XRAY)|Margin dodolan operasi LeMaitre LMAT|Margin operasi ATRC (atricure.com)|ChromaDex Corporation (NAGE) - Rentabilitas dodolan operasi|ZimVie Inc - Margin operasi|Rentabilitas dodolan operasi AngioDynamics|CERS (Cerus Corp) - Margin dodolan operasi|Alpha Teknova, Inc. - Tingkat bathi operasi|MGRM (Monogram Orthopedics Inc.) - Margin operasi|STSS: Tingkat bathi operasi|Margin dodolan operasi INFU (InfuSystem Holdings)|Utah Medical Products, Inc. - Rentabilitas dodolan miturut bathi operasi|Margin operasi KRMD (korumedical.com)|Rentabilitas kegiatan operasi Nyxoah, S.A. (NYXH)|MBOT - Rentabilitas operasi|PDEX (Pro-Dex, Inc.) - Rentabilitas dodolan miturut bathi operasi|ZTEK (Zentek Ltd) - Margin dodolan operasi|ELUT - Rentabilitas kegiatan operasi|MLSS (Milestone Scientific Corporation) - Margin operasi|Rentabilitas dodolan miturut bathi operasi NXGL (NEXGEL, Inc.)|Margin operasi RVP|Margin dodolan operasi Harvard Bioscience HBIO|Margin operasi FEMY (Femasys Corporation)|MHUA - Margin dodolan operasi|POAI - Rentabilitas operasi|Callan JMB (CJMB) - Margin dodolan operasi|ATRI: Margin operasi|NURO - Rentabilitas kegiatan operasi